Alkermes plc

(ALKS) Trade

By |

Profile

Alkermes PLC is a fully integrated, biopharmaceutical company. It applies its scientific expertise and proprietary technologies to research, develop and commercialize pharmaceutical products to address unmet medical needs of patients.

Contact Information

Website: www.alkermes.com
Email: financial@alkermes.com
Main Phone: +353 17728000
Address: 1 Burlington Road
Address 2: Connaught House
City / Town: Dublin
Country: IRL
Postal Code: 4

Issuer Information

Exchange: NGS
CEO: Richard F. Pops
Employees: 2000
Issuer Type: CS - Common Stock
Sector/Industry: Healthcare
NAICS: Pharmaceutical Preparation Manufacturing (325412)
$ 45.39 $ 0.82 (1.84%)
Last Price 45.39 Change $ 0.82 Change % 1.84 Tick N/A
Bid 45.31 Bid Size 100.00 Ask 45.42 Ask Size 200.00
Open 44.37 High 45.76 Low 44.37 Prev Close 44.57
Last Trade Volume 297,703 52 Wk Hi 71.22 52 Wk Low 39.54
Market Cap 7 bi Ex-Div Date N/A Div Rate N/A Yield N/A
Shares 155,037,850.00 EPS (TTM) -0.98 PE Ratio N/A Exchange NGS
  Last 3 Mo Last 12 Mo
Number of Insider Trades 26 147
Number of Buys 11 73
Number of Sells 15 74
Net Activity -15686 139596
Last 10 Buys Shares
David W. Anstice 1,000
Wendy L. Dixon 1,000
Mark Stejbach 1,000
Floyd E Bloom 1,000
David W. Anstice 1,000
Last 10 Sell Shares
James M. Frates 1,000
Paul J. Mitchell 1,000
Michael J. Landine 1,000
Richard F. Pops 1,000
Richard F. Pops 1,000
Michael J. Landine 1,000
Michael J. Landine 1,000
Richard F. Pops 1,000
Richard F. Pops 1,000
Richard F. Pops 1,000
  Current 1 Week Ago 2 Weeks Ago 3 Weeks Ago
High Target Price Estimate 67 67 67 67
Low Target Price Estimate 46 46 46 46
Mean Target Price Estimate 56.13 55.57 55.57 56.13
Standard Deviation 7.32 7.72 7.72 7.32
Date of Most Recent Estimate 06/06/18 05/22/18 05/22/18 06/06/18
  Current 1 Month Ago 2 Months Ago 3 Months Ago
Strong Buy 5 4 2 2
Moderate Buy 0 0 0 0
Hold 5 5 5 4
Moderate Sell 0 0 0 0
Strong Sell 0 0 0 0
Mean Rec. 2 2.11 2.43 2.33